Boston Scientific · 2 weeks ago
Global EME Mechanical Engineer Intern 2026
Boston Scientific is a leader in medical science, committed to solving important health industry challenges. They are seeking a Global EME Mechanical Engineer Intern to assist in designing, developing, and testing Electronic Medical Equipment products, while gaining exposure to a high-performing medical device company.
Health CareMedicalMedical Device
Responsibilities
Use your problem-solving abilities to perform meaningful engineering work
Have opportunities to expand your professional network
Grow your skillset through a combination of training, hands-on experience, and mentorship
Collaborate with cross-functional teams
Get exposure to what it is like working in a high performing medical device company
Qualification
Required
Current rising junior or rising senior (grad dates between Dec 2026 - May 2028), graduating senior (May 2027 grad). Have at least one semester of school left post-internship to qualify
Working towards a Bachelors or Masters degree in Mechanical Engineering or Material Sciences
Must be able to start internship on May 18th or 26th, 2026 and work for 12 weeks
Must have reliable transportation to/from work
Preferred
Familiarity/experience with injection molding and associated materials/polymers
Process oriented
Self-starter and self-finisher
Medical device industry experience
Ability to communicate effectively with diverse, cross-functional teams
Passion to learn new technologies and find new solutions
Benefits
Corporate housing and relocation are available for those who are eligible.
Compensation may also include variable compensation from time to time (e.g., any overtime and shift differential) and annual bonus target (subject to plan eligibility and other requirements).
Compensation may also include variable compensation, i.e., annual bonus target and long-term incentives (subject to plan eligibility and other requirements).
Company
Boston Scientific
Boston Scientific is a medical technology company that designs and develops medical devices to diagnose and treat a wide range of condition.
Funding
Current Stage
Public CompanyTotal Funding
$10.02B2025-02-21Post Ipo Debt· $1.58B
2024-02-22Post Ipo Debt· $2.17B
2022-03-04Post Ipo Debt· $3.28B
Recent News
Star Tribune
2026-01-20
2026-01-19
Boston Globe
2026-01-19
Company data provided by crunchbase